IndonesiaSingaporeMalaysiaVietnamThailandPhilippinesMyanmar
IndiaGreater ChinaRest of AsiaWorld
E-Commerce & Internet EconomyTechnologyReal Estate and InfrastructureFinancial ServicesSocial InfrastructureDeals Barometer

China’s Allist Pharma raises $171m Series A led by Shiyu Capital

China’s Allist Pharma raises $171m Series A led by Shiyu Capital

Medical drugs in a pharmacy. Credit: Flickr/epSos .de

Quynh Nguyen

24 May, 2019

Chinese innovative drugs developer Allist Pharmaceuticals has raised RMB1.18 billion ($170.75 million) in a new funding round led by healthcare-focused private equity firm Shiyu Capital, according to an announcement.

Allist PharmaceuticalsShiyu Capital

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

Related Stories

Private Equity

Chinese PE firm Shiyu Capital raises $473m for second RMB fund

The fund, called Danqing Fund II, has been backed by government-guided funds, insurance companies and overseas-listed pharmaceutical companies.

Deals

China's ambitious healthcare reforms lure India's biggest drug maker

China has rolled out an ambitious multi-city bulk drug procurement program that’s driving down prices and providing an opening for Indian manufacturers like Sun Pharma to compete.

Private Equity

TPG Capital acquires 35% stake in Australian drug testing firm

The deal comes just six months after TPG took over the SE Asian pathology operations of Australian healthcare group Healthscope.

IPOs & Markets

Chinese online drugstore 111 Inc raises $100.5m in US IPO

Shanghai-based online drugstore 111 Inc has raised $100.5 million in a scaled-back initial public offering in the US.
Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2023 All rights reserved.